MEMY - Sector: Healthcare --- Industry: Biotechnology & Drugs

[MarketMakerz]

http://stockcharts.com/def/servlet/SC.web?c=glif

...and they say there is no such a thing as a free lunch!!

[MarketMakerz]

David i would love to hear your input on GLIF

[la-onda]

 
news update:
Memory Pharmaceuticals completes dosing in trial
Tuesday , September 27, 2005 13:00 ET

Sep 27, 2005 (Datamonitor via COMTEX) --Memory Pharmaceuticals has completed the dosing portion of the safety and tolerability study of its drug candidate MEM 1003 in Alzheimer's patients.

The company also expects to commence dosing patients with mild to moderate Alzheimer's disease in a Phase 2a clinical trial in the next several weeks.

"This study has provided us with valuable information about the safety and tolerability of MEM 1003 in Alzheimer's patients, which has been integral to the design of the Phase 2a clinical trial," said Dr David Lowe, chief scientific officer of Memory Pharmaceuticals. "We are now moving forward into the Phase 2a clinical trial with a solid understanding of the safety and pharmacokinetic parameters for this drug candidate."

The Phase 2a proof of concept study for MEM 1003 will evaluate the safety and efficacy of MEM 1003 in patients with mild to moderate Alzheimer's disease.

The safety and tolerability study consisted of two segments, a double-blind dose escalation phase and a double-blind treatment phase. In the first segment of the study MEM 1003 or placebo was administered to 49 patients two times on one day. Patients in this segment of the study were treated at escalating doses of MEM 1003 that reached 120 milligrams per dose. In the double-blind treatment segment, 32 patients received 120 mg of MEM 1003 or placebo twice daily for a period of ten days.

[la-onda]

hanks for the memories
First up today is Memory Pharmaceuticals, which is developing treatments for diseases of the central nervous system. Yesterday brought good news for the company: It has completed the dosing portion of the safety and tolerability tests for MEM 1003, which is aimed at treating Alzheimer's. That means the drug can move into phase 2a clinical trials. Investors cheered the news, sending the stock higher by almost 20%. But I doubt any were happier than board member Jonathan Fleming. His private equity firm, Oxford Bioscience Partners, one of Memory's original investors, on Friday acquired more than 3.1 million shares for two of its funds and warrants to buy 1.1 million more.

That's positively Fristian timing, isn't it? Sure is, but I find it impossible to call shenanigans. It's not like the investing public didn't know this was coming. Last Wednesday, the company announced that it had completed a $31 million private placement to boost its financial position. The "existing investors" mentioned in the press release surely include Fleming's Oxford Bioscience Partners.

http://www.fool.com/news/commentary/2005/commentary05092710.htm?source=eptyholnk303100&logvisit=y&npu=y&bounce=y&bounce2=y

[David Randolph]

Indeed there was heavy insider buying around $1.90 and more is schedule at $2.22 if everything goes as planned. I'm very bullish on this stock, making real progress on its drugs and with just $45.86M in market cap.

Technically a bottom is in place and the trend is turning bullish. I will continue holding MEMY for the foreseeable future.

[puenthouse]

I dont know to laugh or cry.  as bad as all my stocks are doing: i see a little green in my account.  it is that stock memy that i bought. but wait only a 20.00 profit from 8% gain, and then i see i put an order in for 200 instead of 2000.  Cant make mistakes like that, wow i really feel like a novice.  Well just another reminder not to rush and to relook orders.  now im in at 2.52.  i just feel awful

[AussieTrader]

I dont know to laugh or cry.  as bad as all my stocks are doing: i see a little green in my account.  it is that stock memy that i bought. but wait only a 20.00 profit from 8% gain, and then i see i put an order in for 200 instead of 2000.  Cant make mistakes like that, wow i really feel like a novice.  Well just another reminder not to rush and to relook orders.  now im in at 2.52.  i just feel awful

Hey Puenthouse, it happens to everyone. I miscalculated a buy on TZOO once, wanted to get 300 at $35, ended up buying 3,000

[Irishman]

Puenthouse-
  Don't worry about it!! We've ALL done that at one time or another. I'd suggest you try what I did and that is to leave a note on the monitor.  After awhile, it will become second nature to double-check your orders. But don't fret over it. You seem like a very bright guy and you're in good hands here at 3SOF .  I'm quite confident you will do well.  All the best.
  Irish

[voova99]

Hi

May somebody help me .
I don't see subject about the rest of companies - HOM BRVO.OB ..

Best,
Vova

[Ramsburg]

Hi

May somebody help me .
I don't see subject about the rest of companies - HOM BRVO.OB ..

Best,
Vova

Hi vova,

We've changed the navigation system on the boards.
Now, on this board (3 Stocks On Fire) you have only the topics on the open trades.

You can find the previous picks on this board:
http://www.3stocksonfire.org/trading/index.php?board=15.0

PS: BRVO.OB is here

[voova99]

Thank You, Frederick . 

[setravis]

Things are looking very nice...

MEMORY PHARMACEUTICA (NasdaqNM:MEMY) Delayed quote data 

Last Trade: 2.72
Trade Time: 3:25PM ET
Change:  0.54 (24.77%)
Prev Close: 2.18
Open: 2.25
Bid: 2.70 x 6000
Ask: 2.72 x 700
1y Target Est: 6.00

  Day's Range: 2.25 - 2.85
52wk Range: 1.75 - 7.80
Volume: 2,969,516
Avg Vol (3m): 143,183
Market Cap: 57.22M
P/E (ttm): N/A
EPS (ttm): -1.47
Div & Yield: N/A (N/A)

[gmarc66]

Thanks Wrangler!!  ...very sweet

Good luck to everyone holding!!!


julia

[David Randolph]

puenthouse, don't worry too much about each trade, those mistakes happen, think only of long term success. And your entry at $2.52 is probably a good trade too  But thanks for sharing, your experience is good advice ... I won't tell you how much I lost trading the DAX futures a couple of weeks ago because of a similar mistake: I thought I was short but I wasn't, so when I was buying some contracts to take profits I was actually entering long. Since I thought I was flat I turned off the trading system. Only later I found out that I was actually long and losing 50 points. So you're not alone in the mistake family 

Considering MEMY I saw now that the number of shares outstanding is higher than we thought, as you can read on this excerpt from a filing filed with the SEC yesterday before the close:

«Based on 37,153,883 shares of Common Stock of the Issuer outstanding as of September 23, 2005, the Reporting Persons hold approximately 5.7%* of the issued and outstanding Common Stock of the Issuer.»

Marketwatch.com says the number of outstanding shares is 21.04M.

Anyway, I'm really no fundamental analyst and couldn't tell without extremely extensive research what is the fundamental value of MEMY (nobody really knows for sure, since it is all based on projections and value is a subjective thing).

But there's something that tells the value at each moment, and that's the market price. According to the market price, MEMY's value is rising, and those are the kind of stocks that we want.

With much less volume the stock went up to $4.49 just a couple of months ago, who knows where it will go with the recent record volume? I don't know, but I'm willing to let the profits run on MEMY.

[setravis]

Thanks Julia for this nice pick to play....
Once again a very good job....well done trader!!!

Here is a nice link to check out Insider buying....If you don't already have.

http://form4oracle.com/

Lot's of Applaud!!!!!!!!!!!!